Pharma giant AbbVie has closed its $63 billion (€58 billion) acquisition of Botox-maker Allergan, having received the approval of the High Court and of all relevant competition authorities. The deal was first announced last summer.
It got the go-ahead from the Federal Trade Commission in the US last Tuesday after the two companies undertook to sell some products to Nestlé and transfer the rights to a Crohn's treatment that is in development to AstraZeneca.
AbbVie operates from five sites in the Republic between Sligo, Cork and Dublin. Irish-domiciled Allergan operates in Mayo, Dublin and Galway.
AbbVie employs some 600 in the Republic, while Allergan employs around 1,700.